Search research articles
Contact Us
Filters
Showing results (51-60 of 168) with videos related to
Page
of 17
Sort By:
Hospital Medicine (London, England : 1998)
|
August 29, 1998
Diagnosis and treatment of chronic hepatic encephalopathy
J P Seery, R J Aspinall, S D Taylor-Robinson
Alimentary Pharmacology & Therapeutics
|
January 9, 2013
Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy
F J Torlot, M J W McPhail, S D Taylor-Robinson
Gut
|
November 14, 2007
Cholangiocarcinoma and its management
S A Khan, A Miras, M Pelling, et al.
QJM : Monthly Journal of the Association of Physicians
|
January 24, 2021
Why is there a paucity of clinical trials in Africa?
S D Taylor-Robinson, C W Spearman, A A A Suliman
BMJ (Clinical Research Ed.)
|
September 3, 1999
Increased mortality from liver cancer in England and Wales is not related to hepatitis C
S D Taylor-Robinson, H C Thomas, S Arora, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 29, 2020
The COVID-19 era: the view from Nigeria
O O Oleribe, P Oskouipour, O Nwanyanwu, et al.
Journal of Veterinary Internal Medicine
|
April 30, 2014
Plasma adrenomedullin concentrations in critically ill neonatal foals
B Toth, N M Slovis, P D Constable, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Naphthalenebis[alpha,alpha-difluoromethylenephosphonates] as potent inhibitors of protein tyrosine phosphatases
Q Wang, Z Huang, C Ramachandran, et al.
Gut
|
October 8, 2005
In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy
A Cagnin, S D Taylor-Robinson, D M Forton, et al.
Gastroenterology
|
December 1, 1994
Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins
S D Taylor, H C Soudah, W Y Chey, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 168) with videos related to
Sort By:
Page
of 17
Hospital Medicine (London, England : 1998)
|
August 29, 1998
Diagnosis and treatment of chronic hepatic encephalopathy
J P Seery, R J Aspinall, S D Taylor-Robinson
Alimentary Pharmacology & Therapeutics
|
January 9, 2013
Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy
F J Torlot, M J W McPhail, S D Taylor-Robinson
Gut
|
November 14, 2007
Cholangiocarcinoma and its management
S A Khan, A Miras, M Pelling, et al.
QJM : Monthly Journal of the Association of Physicians
|
January 24, 2021
Why is there a paucity of clinical trials in Africa?
S D Taylor-Robinson, C W Spearman, A A A Suliman
BMJ (Clinical Research Ed.)
|
September 3, 1999
Increased mortality from liver cancer in England and Wales is not related to hepatitis C
S D Taylor-Robinson, H C Thomas, S Arora, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 29, 2020
The COVID-19 era: the view from Nigeria
O O Oleribe, P Oskouipour, O Nwanyanwu, et al.
Journal of Veterinary Internal Medicine
|
April 30, 2014
Plasma adrenomedullin concentrations in critically ill neonatal foals
B Toth, N M Slovis, P D Constable, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Naphthalenebis[alpha,alpha-difluoromethylenephosphonates] as potent inhibitors of protein tyrosine phosphatases
Q Wang, Z Huang, C Ramachandran, et al.
Gut
|
October 8, 2005
In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy
A Cagnin, S D Taylor-Robinson, D M Forton, et al.
Gastroenterology
|
December 1, 1994
Duodenal acidification and secretin, but not intraduodenal fat, inhibit human gastric acid secretion via prostaglandins
S D Taylor, H C Soudah, W Y Chey, et al.
Page
of 17